SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 80 filers reported holding SERES THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $51,000 | -96.2% | 2,503 | -94.9% | 0.00% | -100.0% |
| Q4 2020 | $1,327,000 | -12.4% | 49,546 | -7.7% | 0.00% | 0.0% |
| Q3 2020 | $1,515,000 | +39.1% | 53,707 | -72.9% | 0.00% | 0.0% |
| Q2 2020 | $1,089,000 | +84.9% | 197,968 | +6.2% | 0.00% | 0.0% |
| Q1 2020 | $589,000 | +3581.2% | 186,338 | +3947.3% | 0.00% | – |
| Q4 2019 | $16,000 | +23.1% | 4,604 | +43.9% | 0.00% | – |
| Q3 2019 | $13,000 | +116.7% | 3,199 | +85.7% | 0.00% | – |
| Q2 2019 | $6,000 | +500.0% | 1,723 | +538.1% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 270 | +91.5% | 0.00% | – |
| Q3 2018 | $1,000 | -97.7% | 141 | -97.2% | 0.00% | – |
| Q2 2018 | $43,000 | +22.9% | 4,974 | +3.0% | 0.00% | – |
| Q1 2018 | $35,000 | -28.6% | 4,829 | 0.0% | 0.00% | – |
| Q4 2017 | $49,000 | -86.1% | 4,829 | -78.0% | 0.00% | – |
| Q3 2017 | $353,000 | +63.4% | 21,979 | +14.8% | 0.00% | – |
| Q2 2017 | $216,000 | 0.0% | 19,144 | 0.0% | 0.00% | – |
| Q1 2017 | $216,000 | +45.0% | 19,144 | +28.4% | 0.00% | – |
| Q4 2016 | $149,000 | +1762.5% | 14,915 | +2385.8% | 0.00% | – |
| Q3 2016 | $8,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |